undervalued

Im surprised Genetic Signatures only has a market capital of 38 million dolars. It has recently capital raised at 48c and has now operwtions in northern america, and europe, not to mention the patented technology being used in major hospitals around australia. The Std detections kits 100% accuracy, currently only being used for researches purposes only during march 2017. Well we are already nearly through march, and if the std kits become commercial, i believe 38 million market capital is well undervalued.
when you consider RAP being valued at 200million dollars with no revenue, and half a billion dhares on offer, it stumps me why gss is flying under the radar. Gss actually has continued revenue stream (not yet from std kits) and only 104million shares on offer, yet gss are trading roughly the same sp as rap.
I think once deals get signed with major internstional hospitals, and pharmacies, gss is by rights worth 1 billion dollars at least. Maybe more. Definitely more.
70% of the comoany is held by the top 20. So when deals get signed i can see this being hard to buy for less than several dollars a share.
No ramping here just obvious observations.
gl